Skip to main content
Clinical Kidney Journal logoLink to Clinical Kidney Journal
letter
. 2021 Dec 4;15(3):571–573. doi: 10.1093/ckj/sfab239

The rapid development of a novel kidney-specific digital intervention for self-management of physical activity and emotional well-being during the COVID-19 pandemic and beyond: Kidney Beam

Juliet Mayes 1,, Roseanne E Billany 2, Noemi Vadaszy 3, Hannah M L Young 4,5, Ellen M Castle 6,7, Nicolette C Bishop 8, Kate Bramham 9,10, Andrew C Nixon 11, Thomas J Wilkinson 12, Alexander J Hamilton 13, Zoe L Saynor 14, Joseph Chilcot 15, Federica Picariello 16, Jamie Macdonald 17, Sharlene A Greenwood 18,19
PMCID: PMC8690269  PMID: 35198162

Individuals living with chronic kidney disease (CKD) report high levels of physical inactivity and poor emotional well-being [1]. Despite disease-specific guidelines promoting physical activity (PA) participation [2], people living with CKD do not routinely receive PA or emotional well-being support as part of their clinical care [3].

The challenge to engage people living with CKD with PA and emotional well-being interventions was exacerbated by the coronavirus disease 2019 (COVID-19) global pandemic. Specifically, CKD was identified as a significant risk factor for more severe COVID-19 infection [4, 5], and people with CKD were advised to shield at home. The resultant impact on the physical and emotional well-being of these individuals was captured in a Kidney Care UK patient survey, which revealed that 41% of respondents felt anxious, lonely or isolated during the pandemic [6].

The COVID-19 pandemic led to an increase in the use of digital technology and ‘eHealth’ interventions that could deliver aspects of usual and enhanced CKD care. This context led to the current authors rapidly developing and rolling out a kidney-specific PA and emotional well-being platform, Kidney Beam (the promotion was by social media only; no additional technical or clinical support was offered).

The Kidney Beam programme (https://beamfeelgood.com/home) is a contextually appropriate, theory-informed intervention that was designed to promote digitally delivered PA and emotional well-being self-management in people living with CKD, as guided by the Behaviour Change Wheel [7]. The multifaceted digital intervention package was composed of online live and on-demand exercise training videos, careful selection of healthcare professionals and patient champions, use of email feedback and action planning, and online educational videos and blogs.

A 6-month prospective feasibility project was approved by King's College Hospital Research and Innovation team to allow rapid design, delivery and evaluation of Kidney Beam during the COVID-19 pandemic. The project was funded by Kidney Research UK (KRUK). All people in the UK living with CKD aged ≥18 years were eligible to sign up to the platform. Participants consented to complete a voluntary electronic survey on sign up to the platform and at 6 months, to establish whether participants were meeting current PA guidelines, investigate perceptions of health, and collect usability and acceptability data about the platform. Data were collected between 1 June 2020 and 30 November 2020.

In total, 959 adults signed up to use the platform within the 6-month time period (see Table 1). There was a 43% activation rate (people who sign-up to the platform completing one or more classes), which is higher than the UK national average for digital healthcare interventions. More than 1900 movement classes were completed during the 6-month time period. A total of 276 participants completed the voluntary survey at baseline, with 85 completing the follow-up survey at 6 months. Results suggest an increase in those participants achieving recommended PA guidelines and in those participants who perceived their energy levels to be good or very good by the end of the 6-month project (see Table 2). Promisingly, 96% of participants surveyed would recommend Kidney Beam, with the biggest reported benefit being that the intervention was kidney-specific and delivered by specialist kidney healthcare professionals.

Table 1.

Demographic data of participants who signed up to use the Kidney Beam platform

Total users (n) Percentage (%)
Age (years)
 0–18 0 0
 18–25 35 4
 25–35 155 16
 35–45 205 21
 45–55 231 24
 55–65 209 22
 65–75 86 9
 75+ 35 4
 Total 956 100
User type
 Living with condition 736 77
 Exercise or healthcare practitioner 127 13
 Caregiver 34 4
 Other 50 5
 Unknown 12 1
Gender
 Male 249 26
 Female 707 74
 Other 0 0
Kidney Care Clinic
 General Practitioner 121 25
 General Nephrology Clinic 122 25
 Low Clearance Clinic 15 3
 Peritoneal Dialysis Clinic 23 5
 Haemodialysis Clinic 34 7
 Kidney Transplant Clinic 153 32
 Other 14 3
 Total 482 100

Table 2.

Pre- and post-6-month participation voluntary survey results

Baseline, n (%) 6 months, n (%) Percentage change baseline to 6 months (Δ%)
Achieving 150 min of moderate-intensity physical activity (per week) 83 (30) 43 (60) 100
Achieving 75 min of vigorous-intensity physical activity (per week) 97 (35) 36 (42) 20
Achieving twice-weekly strength training 86 (31) 46 (54) 74
Perceived energy levels to be good or very good 55 (20) 26 (30) 50

Digital health interventions that are co-designed with people living with a long-term health condition may result in better clinical and person-centred outcomes [8, 9]. The Kidney Beam programme was rapidly co-developed and delivered with minimal resource during the COVID-19 pandemic. Despite known challenges around digital and health literacy, this digital self-management programme attracted 736 participants living with CKD to sign up to the platform. A randomized controlled waitlist trial is underway to evaluate the feasibility, clinical value and cost-effectiveness of the Kidney Beam programme delivered as part of clinical care (NCT04872933).

ACKNOWLEDGEMENTS

We thank Kidney Research UK for rapidly funding this feasibility project and enabling the platform to be free at the point of access for all individuals living with CKD.

Contributor Information

Juliet Mayes, Therapies Department, King's College Hospital NHS Trust, London, UK.

Roseanne E Billany, Leicester Kidney Lifestyle Team, University of Leicester, Leicester, UK.

Noemi Vadaszy, Leicester Kidney Lifestyle Team, University of Leicester, Leicester, UK.

Hannah M L Young, Leicester Kidney Lifestyle Team, University of Leicester, Leicester, UK; Leicester Diabetes Centre, University Hospitals of Leicester NHS Trust, Leicester, UK.

Ellen M Castle, Therapies Department, King's College Hospital NHS Trust, London, UK; Renal Sciences, King's College London, London, UK.

Nicolette C Bishop, School of Sport, Exercise and Health Sciences, Loughborough University, Loughborough, UK.

Kate Bramham, Therapies Department, King's College Hospital NHS Trust, London, UK; Renal Sciences, King's College London, London, UK.

Andrew C Nixon, Department of Renal Medicine, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK.

Thomas J Wilkinson, Leicester Kidney Lifestyle Team, University of Leicester, Leicester, UK.

Alexander J Hamilton, Population Health Sciences, University of Bristol, Bristol, UK.

Zoe L Saynor, School of Sport, Health and Exercise Science, University of Portsmouth, Portsmouth, UK.

Joseph Chilcot, Renal Sciences, King's College London, London, UK.

Federica Picariello, Renal Sciences, King's College London, London, UK.

Jamie Macdonald, School of Human and Behavioural Sciences, Bangor University, Wales, Bangor, UK.

Sharlene A Greenwood, Therapies Department, King's College Hospital NHS Trust, London, UK; Renal Sciences, King's College London, London, UK.

FUNDING

The feasibility project was a collaboration between King's College Hospital, Kidney Research UK and Beam, a health technology platform supporting people with health conditions to stay physically active. Kidney Research UK did not have any role in study design; collection, analysis and interpretation of data; writing the report; or the decision to submit the report for publication. Juliet Mayes, Pre-Doctoral Clinical Academic Fellow, (NIHR301893), Hannah Young, Development and Skills Enhancement Fellow (NIHR301593), and Sharlene Greenwood, NIHR Advanced Research Fellow (ICA-CL-2017-03-020), are funded by National Institute for Health Research (NIHR) for this research project. The views expressed in this publication are those of the authors and not necessarily those of the NIHR, NHS or the UK Department of Health and Social Care.

AUTHORS’ CONTRIBUTIONS

S.A.G. and J. Mayes contributed to acquisition, analysis and interpretation of data. S.A.G., J.Mayes, R.E.B., N.V., H.M.L.Y., E.M.C., N.C.B., A.H., Z.L.S., J.C., F.P., J. Macdonald, K.B., A.C.N. and T.J.W. contributed important intellectual content during manuscript drafting or revision, and accept accountability for the overall work by ensuring that questions pertaining to the accuracy or integrity of any portion of the work are appropriately investigated and resolved.

CONFLICT OF INTEREST STATEMENT

The results presented in this article have not been published previously in whole or part.

REFERENCES


Articles from Clinical Kidney Journal are provided here courtesy of Oxford University Press

RESOURCES